Plexium
Developer of protein-degrading therapeutics designed to treat cancer and other serious diseases. The company identifies novel small molecules that redirect ligases to targets of interest or induce deg...
Valuation
$200M
Latest known
Share Price
N/A
Total Raised
$225.1M
Last Round
N/A